Episode
The Science and Realities of Long-Term GLP-1 Use
- Podcast
- Weight Loss And ...
- Published
- Jun 24, 2026
- Duration seconds
- 3015
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/weight-loss-and-6741102/episodes/the-science-and-realities-of-long-term-glp-1-use/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/weight-loss-and-6741102/the-science-and-realities-of-long-term-glp-1-use.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Losing weight on a GLP-1 medication can feel like magic until the scale stops moving. For almost everyone on these drugs, there comes a moment when the rapid progress slows, then stalls completely. Is the medication failing? Has your metabolism adapted? Did you do something wrong? For most people, that moment feels like a problem. It isn't. Join Holly and Jim as they unpack one of the most misunderstood parts of the GLP-1 journey: the shift from losing weight to keeping it off. You'll discover why a stalled scale is actually a sign the medication is doing exactly what it's supposed to do, and why "maintenance" is a completely different physiological state than "weight loss." One that comes with its own rules. Along the way, you'll pick up science-backed (and some still-unanswered) guidance on nutrition, muscle, bone health, and motivation for the long haul, plus a clear answer to a question Holly says she gets all the time: Are they against staying on these medications long-term? Discussed on the episode: Why hitting a plateau on a GLP-1 is good news, not a sign the drug has stopped working. The blood pressure pill comparison that reframes what people call "drug resistance" Why nutrition may matter even more, not less, once weight loss stops Whether you actually need to exercise to keep weight off on a GLP-1 (the honest answer might surprise you) The bone health risk in younger women that's getting far less attention than muscle loss Why are dose-tapering and switching strategies being called the "Wild West" of GLP-1 care A New York Times claim about these medications "rewiring the brain" and what that could mean long after you stop. How to find motivation once the scale refuses to budge Have a question or a success story? Send it in. Holly and Jim read every one, and…